Eleonora De Luca

10PUBLICATIONS
32CO-AUTHORS
Epidemiological methodsPharmaceutical delivery technologiesAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Psychiatry (incl. psychotherapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 27, 2026
Effectiveness of Guselkumab for the Treatment of Moderate-to- Severe Psoriasis in Elderly Patients: A Retrospective, Real-World Multicenter Study in the Lazio Region.

|Jul 23, 2026
Sequencing and switching among IL-17 and IL-23 biologics in plaque psoriasis: real-world lessons and precision strategies for the future.

|May 22, 2026
The Psoriasis-Eczema Interface: Clinical Classification and Therapeutic Implications From a Bicentric Experience.

|Jun 27, 2025
Effectiveness of Bimekizumab in Psoriatic Arthritis: A Multicenter Real-Life Study With Clinical and Ultrasound Evaluation in the Lazio Region, Italy.

Giacomo Caldarola, Annunziata Dattola, Nicoletta Bernardini

|Oct 07, 2024
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapies.

Giacomo Caldarola, Eleonora De Luca, Gennaro Marco Falco

|Jun 28, 2024
Successful Use of Dupilumab in the Treatment of Acquired Perforating Dermatosis Associated with Atopic Dermatitis.

Niccolò Gori, Eleonora De Luca, Andrea Chiricozzi

Pageof 2

Frequent Collaborators

6 joint publications

Giacomo Caldarola

4 joint publications

Ketty Peris

3 joint publications

Clara De Simone

2 joint publications

Andrea Chiricozzi